NEW YORK (GenomeWeb News) – Researchers at the Biodesign Institute at Arizona State University and Phoenix Children's Hospital will team up to use genome sequencing to study the molecular basis of desmoplastic small round cell tumor (DSRCT), a deadly pediatric cancer.

The three-year project, funded with a $250,000 grant from the non-profit Hyundai Hope on Wheels organization, will fund genome sequencing efforts at the Center for Personalized Diagnostics at the Biodesign Institute and bioinformatic analyses of pediatric DSRCT tumor samples, ASU said this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.